Studies using animal models have shown that conditions linked to metabolic and cardiovascular dysfunction, e.g. obesity, diabetes, heart disease, can be modified by manipulation of BDNF in the brain and in the peripheral circulation [6]. This evidence concerns the gene BDNF and obesity disorder.